62 results  1 of 4 

1 A survey evaluating hematology physicians’ perspectives on central nervous system prophylaxis
Ufuk Demirci, Meltem Kurt Yüksel, Hakkı Onur Kırkızlar, Elif Birtaş Ateşoğlu, Özgür Mehtap, Ozan Salim, Ahmet Muzaffer Demir, Olga Meltem Akay
Blood Res.2023;58(2):99-104.   Published online 2023 June 8     DOI: http://dx.doi.org/10.5045/br.2023.2023066
      
2 Diffuse large B-cell lymphoma presenting as transverse myelitis
Urchiyev Zukhriddin, Jin-Ju Kang, Myoung-Ja Jeong, Sun-Young Oh
Ann Clin Neurophysiol.2022;24(2):79-83.   Published online 2022 October 31     DOI: http://dx.doi.org/10.14253/acn.2022.24.2.79
      
3 A Case of Primary Diffuse Large B Cell Lymphoma of the Maxillary Sinus Presenting as Epiphora
Young Bin Yun, Woo Yong Bae, Sangjun Kim, Min Gyoung Pak
J Rhinol.2022;29(2):112-117.   Published online 2022 July 27     DOI: http://dx.doi.org/10.18787/jr.2021.00397
      
4 Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts
Jun Ho Yi, Seong Hyun Jeong, Seok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, Youngil Koh, Jin Seok Kim, Won-Sik Lee, Deok-Hwan Yang, Young Rok Do, Min Kyoung Kim, Kwai Han Yoo, Yoon Seok Choi, Whan Jung Yun, Yong Park, Jae-Cheol Jo, Hyeon-Seok Eom, Jae-Yong Kwak, Ho-Jin Shin, Byeong Bae Park, Seong Yoon Yi, Ji-Hyun Kwon, Sung Yong Oh, Hyo Jung Kim, Byeong Seok Sohn, Jong Ho Won, Dae-Sik Hong, Ho-Sup Lee, Gyeong-Won Lee, Cheolwon Suh, Won Seog Kim
Cancer Res Treat.2023;55(1):325-333.   Published online 2022 April 22     DOI: http://dx.doi.org/10.4143/crt.2022.008
      
5 Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma
Do Young Kim, Jehyun Nam, Joo-Seop Chung, Byeol Eun Jeon, Ji Hyun Lee, Jae-Cheol Jo, Sang-Woo Kim, Ho-Jin Shin
Cancer Res Treat.2022;54(4):1256-1267.   Published online 2021 December 31     DOI: http://dx.doi.org/10.4143/crt.2021.944
      
6 Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study
Seong Hyun Jeong, Seok Jin Kim, Dok Hyun Yoon, Yong Park, Hye Jin Kang, Youngil Koh, Gyeong-Won Lee, Won-Sik Lee, Deok-Hwan Yang, Young Rok Do, Min Kyoung Kim, Kwai Han Yoo, Yoon Seok Choi, Hwan Jung Yun, Jun Ho Yi, Jae-Cheol Jo, Hyeon-Seok Eom, Jae-Yong Kwak, Ho-Jin Shin, Byeong Bae Park, Shin Young Hyun, Seong Yoon Yi, Ji-Hyun Kwon, Sung Yong Oh, Hyo Jung Kim, Byeong Seok Sohn, Jong Ho Won, Se-Hyung Kim, Ho-Sup Lee, Cheolwon Suh, Won Seog Kim
Cancer Res Treat.2022;54(4):1268-1277.   Published online 2021 December 30     DOI: http://dx.doi.org/10.4143/crt.2021.1168
      
7 An unusual case of microsatellite instability–high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing
Bogyeong Han, Sehui Kim, Jiwon Koh, Jeong Mo Bae, Hongseok Yun, Yoon Kyung Jeon
J Pathol Transl Med.2022;56(2):92-96.   Published online 2021 November 16     DOI: http://dx.doi.org/10.4132/jptm.2021.10.15
      
8 Sciatic nerve neurolymphomatosis as the initial presentation of primary diffuse large B-cell lymphoma: a rare cause of leg weakness
Kyoung Tae Kim, Se Il Kim, Young Rok Do, Hye Ra Jung, Jang Hyuk Cho
Yeungnam Univ J Med.2021;38(3):258-263.   Published online 2021 April 15     DOI: http://dx.doi.org/10.12701/yujm.2021.00983
      
9 Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study
Hee Sang Hwang, Meejeong Kim, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh, Jooryung Huh, Heounjeong Go
Cancer Res Treat.2021;53(1):270-278.   Published online 2020 September 15     DOI: http://dx.doi.org/10.4143/crt.2020.626
      
10 Metachronous extranodal natural killer/T-cell lymphoma of nasal type and primary testicular lymphoma
Young-In Maeng, Sun-Jae Lee
Yeungnam Univ J Med.2020;38(3):231-234.   Published online 2020 September 11     DOI: http://dx.doi.org/10.12701/yujm.2020.00675
      
11 Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens
Heyjin Kim, Hee-Jin Kim, Sun-Hee Kim
Ann Lab Med.2020;40(5):361-369.   Published online 2020 September 1     DOI: http://dx.doi.org/10.3343/alm.2020.40.5.361
      
12 Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL Axis
Ling Chen, Cheng-Zhi Zhan, Tao Wang, Hua You, Rui Yao
Yonsei Med J.2020;61(1):20-29.   Published online 2019 December 23     DOI: http://dx.doi.org/10.3349/ymj.2020.61.1.20
      
13 Paraneoplastic demyelination in the brain presenting as a clinically occult non-Hodgkin's lymphoma
Hyoshin Son, Jongsuk Choi, Sung Un Kim, Kyung Seok Park
Ann Clin Neurophysiol.2019;21(2):108-112.   Published online 2019 July 30     DOI: http://dx.doi.org/10.14253/acn.2019.21.2.108
      
14 Diffuse Large B-Cell Lymphoma Arising within Ileal Neobladder: An Expanding Spectrum of Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation
Hyekyung Lee, Hyunbin Shin, Nae Yu Kim, Hyun Sik Park, Jinsung Park
Cancer Res Treat.2019;51(4):1666-1670.   Published online 2019 March 22     DOI: http://dx.doi.org/10.4143/crt.2019.022
      
15 A case of diffuse large B-cell lymphoma of the uterus and ovary
Sang Hoon Lee, Kyung Jin Min, Keum Joon Cho, Soon Cheol Hong, Sang Wook Yoo, Nam Hee Won, Kyu Wan Lee
Korean J Gynecol Oncol.2005;16(4):366-370.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgo.2005.16.4.366
      
16 Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Xueying Li, He Huang, Bing Xu, Hongqiang Guo, Yingcheng Lin, Sheng Ye, Jiqun Yi, Wenyu Li, Xiangyuan Wu, Wei Wang, Hongyu Zhan, Derong Xie, Jiewen Peng, Yabing Cao, Xingxiang Pu, Chengcheng Guo, Huangming Hong, Zhao Wang, Xiaojie Fang, Yong Zhou, Suxia Lin, Qing Liu, Tongyu Lin
Cancer Res Treat.2019;51(3):919-932.   Published online 2018 October 2     DOI: http://dx.doi.org/10.4143/crt.2018.230
      
17 Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era
Jihoon Kang, Shinkyo Yoon, Cheolwon Suh
Blood Res.2017;52(4):276-284.   Published online 2017 December 26     DOI: http://dx.doi.org/10.5045/br.2017.52.4.276
      
18 Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphoma
Hyun-Young Kim, Mi-Ae Jang, Hee-Jin Kim, Seok Jin Kim, Won Seog Kim, Sun-Hee Kim
Blood Res.2017;52(3):193-199.   Published online 2017 September 25     DOI: http://dx.doi.org/10.5045/br.2017.52.3.193
      
19 Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01
Jung Hye Choi, Tae Min Kim, Hyo Jung Kim, Sung Ae Koh, Yeung-Chul Mun, Hye Jin Kang, Yun Hwa Jung, Hyeok Shim, So Young Chong, Der-Sheng Sun, Soonil Lee, Byeong Bae Park, Jung Hye Kwon, Seung-Hyun Nam, Jun Ho Yi, Young Jin Yuh, Jong-Youl Jin, Jae Joon Han, Seok-Hyun Kim
Cancer Res Treat.2018;50(2):590-598.   Published online 2017 June 9     DOI: http://dx.doi.org/10.4143/crt.2017.172
      
20 Malignant lymphoma on parotid gland: a clinical case
Hyeong-Geun Lee, Jae-Yeol Lee, Jae-Min Song
J Korean Assoc Oral Maxillofac Surg.2017;43(2):138-143.   Published online 2017 April 25     DOI: http://dx.doi.org/10.5125/jkaoms.2017.43.2.138
      

 1 of 4